Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I acknowledge that what I believe to be the facts are only what is contained in GTHP's filings with the SEC.
I am really only trying to participate in a discussion, and I appreciate your participation. It's an academic duscussion for me because I don't think SMI is going to pay Guided 2.2 million. Frankly, I'm only here for the FDA play in the USA -- I don't have much faith in the "China Play" of SMI. They might actually submit an application to the NMPA (fka CFDA), but I'd be very surprised if SMI has $2.2 million USD. They look like a small entity that does little more than manufacture glass blood collection tubes.
I do think the Chinese study will help Guided get US FDA approval. Can't hurt.
I will try to follow the Conte trial in March. You should keep us posted. Thanks!
SMI was promising to pay $1 Million so they got what they wanted a New Direct Licensing Agreement with GTHP.
Shenghou Medical LLC now know as K2 to relinquish and give up their contractual rights under the original Licensing Agreement got a Royalty Type payment arrangement either in the form of their Existing Original Licensing Agreement being amended or Shenghou Medical LLC, now K2 getting an new Royalty Type Payment Agreement (I cannot remember which form).
I will state under the pains and penalties of perjury that when SMI paid monies to GTHP, GTHP then subsequently as required in their agreement with Shenghou Medical LLC, now K2 did in fact receive royalty type payments from GTHP which GTHP was required to pay the same per its agreement with Shenghou Medical, LLC now K2.
GetSerious just have your attorney send Mark Faupel and Richard Blumberg a certified letter inquiring which it was, I will pay your legal bill and then you will know i was only referring to your facts not being correct.. I have no problem with you on a personal level and when you come to realize what I am saying is true maybe you will spear head and SEC complaint for non disclosures.
that "royalty interest" you describe is not documented anywhere and it contradicts what GTHP filed with the SEC.
So you're asking me to believe YOU, an anonymous poster on a message board, instead of the legal SEC filings of a publicly traded company.
You see how that would be hard for me to do, right?
I think Shenghou gave up contractual rights simply because they couldn't fulfill their part of the contract. That doesn't entitle them to royalty payments or any other kind of payment.
If Shenghou "found SMI" to keep their GTHP agreement alive, they would sub-contract with SMI and keep dealing with GTHP themselves. That didn't happen. SMI is dealing directly with GTHP. Shenghou is not part of that agreement in any way. At least, that's what the SEC filings say. You want me to believe that GTHP is lying in their SEC filings, and without proof, I am not going believe that.
No point in discussing this further unless you want to match the proof I offered from the SEC filings with contradicting proof that there's a legal agreement between Shenghuo and GTHP stipulating that Shenghuo gets a royalty from SMI payments.
Shenghou Medical, LLC shareholders have always been comprised of Richard Blumber, who has also always been its manager, and Mark Faupel, who has always been a shareholder and at one point in time also a manager. Shenghou Medical LLC, now know as K2 had the original license with GTHP, despite having no expertise to satisfy its obligation to perform the same so it found SMI to enter into a new arrangement with GTHP. Because Shanghou Medical LLC gave up contractual rights it received a royalty interest from any monies GTHP would receive from SMI. GTHP did in fact receive monies from SMI and subsequently GTHP then did in fact paid a portion of the monies it received out to Shenghou Medical LLL now know as K2. GTHP is contractually obligate to pay Shenghou Medical, LLC now as "K2" royalty type payments on any monies GTHP receives from SMI.
I am not responsible for others failures to make required SEC disclosures.
I am a shareholder of GTHP so perhaps you are right with voicing shareholder concerns for non disclosures and any ramifications for the such non disclosures if that proves to be the case.
You criticize me for not believing the word of an anonymous poster on a message board. Sorry, but that's just how I am. I choose to believe GTHP's filings with the SEC until I see contradicting proof.
(Well, sort of anonymous -- I think we know better, don't we? Who would post insider information from the Conte case other than...... ????)
You insist that "SMI owed GTHP $1 Million" but where is that documented? That would be booked as uncollected debt on the balance sheet. Where in GTHP's filings is this booked?
GTHP owed Shenghou money for loans, so it doesn't surprise me that GTHP paid Shenghuo money when they had it, but where is the contractual agreement that says GTHP is OBLIGATED to pay Shenghuo money when/if SMI makes a payment? That makes no sense. Maybe Faupel and/or Blumberg make this claim but I won't believe that until I see it documented in GTHP's filings with the SEC. That contradicts what they DID say in their filings.
The Conte lawsuit is for a $64,000 loan that is under dispute as to whether it was convertible or not. (Conte signed a contract without reading it -- who would do that? Seems shaky to me but the judge is going to allow the case to go to trial.) That's between Faupel, Blumberg, and Conte. GTHP is not involved.
What you are describing contradicts the description GTHP filed with the SEC in every 10-Q and 10-K and prospectus filed in the past five years.
So either GTHP lied in all their SEC filings and you are now disclosing insider information, which is illegal....
OR
You are confused.
I'm assuming you're disclosing information from the depositions from the Conte case. If you're going to disclose that information, quote the depositions directly. I think the problem here lies in a faulty interpretation of what Faupel and Blumberg actually said.
SMI owed GTHP $1 Million and SMI only made partial payments on this (Mark Faupel and Richard Blumberg refused to provide me with the full amount of payments made by SMI to GTHP) SMI did not pay the full $1 Million amount to GTHP, and out of the monies GTHP did in fact receive, GTHP subsequently made payments to Shenghou Medical LLC, now know as K2, as GTHP is obligated to do the same as I have stated.
If you say such should have been disclosed and was not, is that a big surprise to you given that Mark Faupel and Richard Blumberg are each individually being sued in Massachusetts for unfair and deceptive trade practices in Massachusetts for conduct they engaged in against one of the share holder owners, GIUL, LLC in Shenghou Medical, LLC. That lawsuit on it own should speak for its self. I am not going to continue to engage with your misconception which you have based your opinion on.
Those are not undisputed facts -- they are misconceptions on your part, IMO.
What you are describing would be an agreement between SMI and Shenguo. You are describing Shenghuo hiring SMI as a sub-contractor. In that arrangement, SMI would pay Shenghuo directly.
If it were true that "GTHP is obligated to share fees (it receives from SMI) with Shenghou Medical, LLC " then that would be described in GTHP's filings. It is not. You're asking us to believe something that is undocumented simply because you say it's true. Sorry, can't do that.
We understand that you have an axe to grind with Faupel and Blumberg. You must be the guy who is suing them. What do you gain by bashing GTHP on this MB? How does that increase your odds of winning the court case against Faupel and Blumberg?
SMI may have paid GTHP some money but it wasn't much -- if you disagree, name the quarter in which SMI's payments show up on the balance sheet. And that $1 million was part of the agreement between Shenghuo and GTHP, not SMI and GTHP.
GTHP doesn't owe Shenghou any money that is contingent upon SMI making a payment. SMI and Shenghuo are completely independent of each other. Any money paid by SMI to GTHP is the property of GTHP, not the property of Blumfeld or Faupel. If GTHP want to repay Shenghup for some past loans, thry can, but they are not contractually obligated to do so if/when SMI pays anything.
Faupel and Blumberg may or may not have to pay Conte some money but GTHP is not a defendant in Conte's lawsuit.
I understand that you are upset about (and perhaps involved in) the Conte case. Perhaps a different message board would be a better place to complain about that matter.
Additional FACTS, SMI did pay some of the $1 million to GTHP and out those monies GTHP DID IN FACT MAKE CORRESPONDING PAYMENTS TO Shenghou Medical, LLC now know as K2, at one time Faupel was both an owner and manager of this entity now he is only an owner, at all times Richard Blumberg has been both an owner and manager of Shenghou Medical, LLC now know as K2.
That Shenghou is the original license holder with GTHP and because Shenghou had no expertise to satisfy its obligation under the same, Shenghou had to find a substitute like SMI. SMI became a new Licensee and substituted into a New Licensing Agreement between SMI and GTHP, under which SMI was to pay GTHP $ I million which it never fully paid. Because Shenghou Medical, LLC (now K2) gave up rights it became untitled to receive and participate in fees SMI is obligated to pay to GTHP,.
When and if GTHP collects fees under its agreement with SMI, GTHP is obligated to share fees with Shenghou Medical, LLC now K2, which Richard Blumberg is both a manager and owner in K2. Mark Faupel at one time was both a manager and owner in K2, now Faupel is just an owner in K2.
GTHP is obligated to share fees (it receives from SMI) with Shenghou Medical, LLC now K2. Those are undisputed facts.
You've got that all wrong. GTHP doesn't have to give Shenghuo a dime of any SMI payment. Shenghuo and SMI are completely independent of each other. GTHP doesn't owe Shenghuo any royalties or percentages because Shenghuo didn't fulfill their part of the agreement.
IF SMI pays, GTHP, then in turn GTHP has to pay some monies out to Shenghou, LLC now know as "K2" the original license holder.
More importantly Shenghou, LLC now K2 did not have the expertise to satisfy the terms of the original license agreement with GTHP (so why would that agreement have been entered into?) and Shenghou now K2 had to find a substitute like SMI or else Shenghou LLC (now K2) would loose the License Agreement with GTHP.
The really fishy smell here is that both Mark Faupel and Richard Blumberg are owners of Shenghou LLC (now K2). I will leave it at that for now!
EPS and PE for a developmental biotech without earnings..... yeah right.
You can stop the trolling. Everyone here is on to your game.
Anyone would like to comment?
If SMI pays GTHP 2.2 ML$, then how much will be their revenue, how much will be their net income? How much will be their EPS? What’s the PE for GTHP/this sector? & then how much (potentially) high the stock price may go?
Homey don't play dat game.
What I meant was, in this entire year the bid has been stubbornly sitting at either 0.126$ or 0.136$
So assuming SMI pays 2./ ML$ to GTHP then will bid will go up than 0.15$ and subsequently the stock price? If yes, then how much (potentially) high it can go?
it's above 15 cents NOW.
Let’s be positive and assume that SMI will pay 2.2 ML$ to GTHP. In this great scenario will GTHP stock finally go above 0.15$.
If it will then how much high (potentially) it may go? Any optimistic guesses?
When did SMI "owe" Guided $1 million? I don't see that on the financial reports. SMI failed to pay Guided money on several occasions but Guided didn't deliver product to SMI so Guided wasn't "owed" $1 million, as far as I can tell.
If SMI owed Guided money and didn'y pay it, Guided would write that off as bad debt. In which quarter did that happen?
And when/why would Faupel have any say in the matter? Cartwright was CEO when SMI replaced Shenghuo Medical as the China distributor and still CEO when SMI re-negotiated the most recent agreement.
Regardless -- it certainly appears that Chinese clinical trials have been completed, and Guided didn't have to pay for it, so if those Chinese researchers publish their results it's a win, even if SMI never pays Guided a red cent.
Mark Faupel never made SMI pay the full $1 Million that GTHP was owed by SMI. That was revealed in GIUL deposition of Mark Faupel and Richard Blumberg.
As I'm sure you saw in the 11/20 PR, SMI says they've completed those last 12 patients and:
I've exposed FOUR lies you told. Can you reveal ONE lie I told? No, you can't, because I am not a liar.
Do you not see the difference between LYING and expressing a critical opinion?
Yes, I am skeptical of SMI, but I never LIED about them. I'll say something positive about SMI when they pay the $$$ millions they've been promising.
That might actually happen, maybe even in Q4 2023 or Q1 2024, but until it shows up on the balance sheet, I'm not going to falsely praise SMI. They signed many agreements with Guided that had to be re-negotiated when SMI failed to deliver what they promised. That is the documented truth.
You never said anything positive about SMI.
You always criticized SMI.
SMI have proved that YOU are nothing but LIAR & FRAUD.
You have NEVER said a positive thing about GTHP with EITHER of your aliases.
I have nothing new to add because the company has nothing new to add. When there's something new. I post it. Until then, I'll just keep exposing you for the fraud that you are. If exposing your lies and deceit is a "personal attack" then so be it.
Have a wonderful weekend.
All of us here want stock price to go up.
Instead of personally attacking me if you have any value add to post then post on this forum.
Your personal attacking posts don’t add any value.
I’ve ignored you in the past but you kept on personally attacking me.
Do you have any value add to post?
Sorry, am I interfering with your bashing?
Remember post #15344 where you claimed to be ignoring me? Just another lie from you, I see.
Remember when you said that the CEO stole all the money?
Remember when you said the Officers and Directors were fake names and didn't exist?
Remember when you said they'd never start US clinical trials?
Remember when you used two aliases to simulate a conversation?
Luckily if would be better if YOU keep your mouth shut!
Luckily, we have YOU watching this.
Impossible for this stock price to go up than 0.15$.
As long as there are heavy selling investors at a bargain basement price of 0.1310-0.1320$, it’s impossible for the stock price to go up than 0.15$.
Bid is not at all increasing and ask keeps going down-&-down.
No hopes for this stock price.
Yesterday CFGN was the broker on Bid side and CFGN was the broker on Ask side. The trade of almost 6K happened at bid price. After that when OTCN became broker on bid side all of a sudden no trade happened. The same pattern was observed so many times before in GTHP stock trading. This same pattern was notified to SEC & FINRA. Both these regulators are closely monitoring/watching activities of these 2 broker-dealers/MMs CFGN & GTSM.
A broker is on the bid side & the same broker is on the ask side. How’s that normal & legal?
A broker is on the bid side & the same broker is on the ask side & sell always happens on bid price. How come a seller always lowers price & sells stock at bid price? How’s that normal & legal?
I understand what you SAID but I don't understand what you MEAN.
You are describing normal legal MM activity in a thinly traded OTC stock.
You are not understanding what I said. I said on bid side & ask side it’s always the same broker. Whether it’s GTSM or CFGN etc. & all the time seller lowers price & the trade happens at bid price. That’s just plain manipulation of stock prices these brokers have been already reported at FINRA & SEC.
What in the world are you talking about?
There was a bid at 0.136$ & an ask at 0.16$ and a trade happened at 0.136$ -- what is your point? A seller dropped to .136 and that is illegal or unethical in your eyes?
Yes it was 7500 volume.
Today also CFGN had a bid at 0.136$ & CFGN had an ask at 0.16$. The trade of 25K happened at 0.136$.
CFGN’s all this “activity” is being reported to SEC.
Did you take a look at the volume of those trades?
Did you take a look at what price did it close today?! In spite of this news, people are still willing to sale at 0.1260$.
Although last trade is suspicious. CFGN had a bid at 0.1260$ & CFGN had ask at 0.16$ & the trade happened at 0.1260$
CFGN is already under SEC watch & today’s suspicious trade was also reported to SEC.
I don't think anyone believes the SMI hype because SMI has been promising the moon for many quarters, but wouldn't that be nice if SMI actually paid the $2.2 million they've been promising.
It wouldn't book until Q1 2024 but that would be a nice $$$ bump coming at a good time for Guided. And it's no skin off Guided's back if SMI never ponies up, as long as somebody actually files the trial results with the NMPA (fka the CFDA).
Come on, there is no heavy ANYTHING. No heavy selling and no heavy buying either.
There was heavy selling once, back in June, but that was short-lived. We've all been waiting for that seller to return but I think they liquidated and that was a once-in-a-lifetime buying opportunity.
Remember that? When you called everyone who said they were buying a liar?
Oh and about the news today -- if you can't find that PR then you're hopeless. It's a PR, man. It's on BusinessWire if that helps.
Can you please post the link of that great news?
If the news would have been great then bid would have gone up. Each & every uptick in bid is taken & then heavy selling resumes.
Great news out let’s see what next$$$
Absolutely no hope for this stock. Any uptick in bid is immediately taken & heavy selling resumes. Extremely bearish!
I think you meant "extremely boorish."
Whether it’s China or US, it doesn’t matter. There’s absolutely no interest from anyone in buying this stock. If (& it’s a very big if) they announce a substantial good news then only there will be any interest. It’s very hard & difficult for this stock’s bid to go up than 0.125$
Oh I thought China was and open book and always told the truth about everything?
Also look at the trading of GTHP stock in this entire year. You will find there are absolutely no buys for this stock because there’s no buying interest for this stock,
There are only sells & only sellers & all sellers want to sell at any salvage price they can get. As if sellers just want to get out of their long positions. Any slightest uptick in bid price is immediately taken/claimed and then heavy selling resumes. Unless bid goes up there’s no hope for this stock.
If you think this is way undervalued then where are your buys?!
When there are 2750 stock sell at a bargain basement price of 0.125$, obviously the seller knows something (bad) that you & I don’t know.
Chinese were supposed to complete trial by 1st, 2Q end ‘23, then they were supposed to complete it by 3Q end ‘23 & they are still not complete. You can get the picture!
Followers
|
106
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
15707
|
Created
|
11/06/16
|
Type
|
Free
|
Moderators GetSeriousOK |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |